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Available online 29 December 201112(S)-Lipoxygenase (LOX) and its product 12(S)-hydroxyeicosatetraenic (HETE) acid have been
implicated in angiogenesis and tumour invasion in several tumour types while their role in
colorectal cancer progression has not yet been studied. We have analysed 12(S)-LOX expression
in colorectal tumours and found gene expression up-regulated in colorectal cancer specimens
for which the pathology report described involvement of inflammation.
Using cell line models exposed to 12(S)-HETE or over-expressing 12(S)-LOX malignant cell
growth as well as tumour cell migration was found to be stimulated. Specifically, Caco2 and
SW480 cells over-expressing 12(S)-LOX formed fewer colonies from sparse cultures, but migrated
better in filter-migration assays. SW480 LOX cells also had higher anchorage-independent growth
capacity and a higher tendency to metastasise in vivo. Knock-down or inhibition of 12(S)-LOX
inhibited cell migration and anchorage-independent growth in both 12(S)-LOX transfectants
and SW620 cells that express high endogenous levels of 12(S)-LOX. On the cell surface E-
cadherin and integrin-β1 expression were down-regulated in a 12(S)-LOX-dependent manner
disturbing cell–cell interactions. The results demonstrate that 12(S)-LOX expression in inflamma-
tory areas of colorectal tumours has the capacity to induce an invasive phenotype in colorectal
cancer cells and could be targeted for therapy.
© 2011 Elsevier Inc. Open access under CC BY-NC-ND license.Keywords:
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Lipoxygenases (LOX) and their eicosanoid products are involved
in many physiological and pathophysiological processes like
growth, differentiation, vascularisation, inflammation and arte-
riosclerosis [1,2]. Specifically, 12- and 15-LOX enzymes haveResearch, Department of M
n.ac.at (B. Marian).
ydroxyeicosatetraenic acid
ript equally.
C BY-NC-ND license.been described as regulators of inflammation and immune-
response [3]. Leukocyte, reticulocyte and epidermal forms of
the enzyme are well characterised as to their product pattern
and physiological function [3–5]. By contrast, the platelet-
derived 12(S)-LOX (ALOX12) is still insufficiently understood.
It produces almost exclusively 12(S)-hydroxyeicosatetraenicedicine 1, Medical University Vienna, Borschkegasse 8a, 1090 Vienna,
; LOX, lipoxygenase.
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survival factor in gastric [8], pancreatic [9], melanoma and pros-
tate tumour cells [10,11] and to induce a metastatic phenotype
in prostate cancer [12]. In addition 12(S)-HETE may also affect
other tissue components to enhance neovascularisation and
tumour progression [10,12–15]. For this reason 12(S)-LOX is
regarded as a protumorigenic gene [16]. Protumorigenic roles
of LOX-enzymes are also suggested by the observation that in-
hibitors of LOX isoenzymes like quercetin, nordihydroguaretic
acid or baicalein can protect from carcinogenesis in both the
skin and the colon [17–19]. Such inhibitors are not specific for
individual LOX enzymes, however, so that a more specific ap-
proach is needed to demonstrate the actual role of 12(S)-LOX
in tumour development.
In colorectal cancer protumorigenic impact has been un-
equivocally demonstrated for cyclooxygenase 2 (COX-2) and
its prostaglandin products [20] as well as for 5-LOX and its
product leukotrien B4 [21,22]. Concerning 12(S)-LOX a genetic
polymorphism that produces a more active enzyme is related
to a higher cancer risk [23] suggesting that there is a protu-
morigenic impact of 12(S)-LOX on CRC. The pathophysiological
impact of the enzyme on CRC has not yet been analysed in any
detail, however. This study therefore, undertakes to determine
the expression of 12(S)-LOX in colorectal carcinomas as com-
pared to normal mucosa as well as the cell biological conse-
quences of 12(S)-HETE and 12(S)-LOX expression in colorectal
tumour cell lines.Materials and methods
Tissue specimen
Tissue specimens were obtained from colorectal carcinomas and
normal tumour-free mucosa at the resection margin from patients
suffering from colorectal cancer. The study has been approved by
the local ethics committee and the patients had given their in-
formed consent. The tissue specimens were collected immediately
after surgery and frozen in liquid N2 until extraction.
Cell lines and transfection
SW480, SW620, and Caco2 colon carcinoma cells were obtained
from the American Type Culture Collection. The cell lines were
kept under standard tissue culture conditions using Minimal
Essential Medium (MEM) containing 10% fetal calf serum (FCS).
12(S)-LOX over-expressing SW480 and Caco2 cells were pro-
duced by electroporation as described before [24]. Populations
stably over-expressing 12(S)-LOX were cultivated in the presence
of 1.6 and 0.2 mg/ml geneticin (G418) respectively.
Eicosanoid mediators, inhibitors and cell treatment
12(S)-HETE (0.1 mg/ml in ethanol) was purchased from Cayman
chemicals (Ann Arbor, MI). Arachidonic acid (AA) and baicalein
were obtained from Sigma (St. Louis, MO). Cells were plated at a
density of 5×104 in 24-well plates and left to attach for 24 h be-
fore exposure to the compounds diluted into HEPES-buffered
MEM containing 1 mg/ml bovine serum albumin (BSA). Experi-
ments on 12(S)-LOX transfectants and their respective controlswere done in the presence of 10 μM AA to provide sufficient sub-
strate for eicosanoid synthesis.
Growth parameters
Viable cell number was determined by neutral red uptake as
reported previously [24].
For clonogenicity assays cells were plated at a density of 100
cells/well (SW480) or 200 cells/well (Caco2, SW620) into six-
well plates in growth medium. Unattached cells were removed
24 h later and the cultures then left to grow for 7 days. The
number of colonies was assessed after staining with crystal
violet.
Anchorage-independent growth was determined from 5000
cells/well in 0.25% agar prepared in RPMI medium containing
20% FCS and incubated for 2–3 weeks before counting the number
of colonies microscopically.
Cell migration assay
Cell migration was analysed by filter migration assay as described
before [25]. Specifically, 0.5×105 cells/cm² were seeded into 8-
μm-pore-size filters (Becton Dickinson-Falcon, Franklin Lakes,
NJ) and migration periods of 24 h (SW480, SW620) or 48 h
(Caco2) were permitted.
Tumour growth in vivo
SW480-LOX and SW480-co cells were harvested, washed with
PBS, and suspended in Ringer's solution. 1×106 cells in 50 μl
Ringer's solution were subcutaneously injected into the rear
flanks of immunodeficient SCID/Balb/c recipient mice (female,
aged 4 weeks, Harlan Winkelmann, Borchen, Germany). Tu-
mour formation was monitored periodically by palpation,
and the tumour size was determined using a Vernier caliper.
Tumour volume was calculated using the formula (smaller
diameter2× larger diameter)/2. All experiments were per-
formed in triplicate and carried out according to the Austrian
and FELASA guidelines for animal care and protection. Tissue
sections of experimental tumours were analysed by immuno-
histochemistry using antibodies directed against cytokeratin
20.
Mouse lungs were prepared for immunohistochemistry and
stained with a monoclonal antibody recognising Ki67 (Novacastra,
Leica Microsystems, Wetzlar, Germany). Serial sections were
scored for Ki67-positive cells/field of vision and the following
scores were assigned: <1 cell/field=0, 1–5 cells/field=1; 5–10
cells/field=2; 10–20 cells/field=3; >20 cells/field=4.
Knock-down of 12(S)-LOX expression
To knock down 12(S)-LOX expression 400 pmol (Caco2 transfec-
tants), 10 nmol (SW480 transfectants) or 30 nmol (SW620 cells)
of an antisense phosphothioate oligonucleotide directed against
12(S)-LOX with the sequence 5′-CTCAGGAGGGTGTAAACA-3′
[26] was introduced by lipofection. Lipofectamin (Invitrogen
Life Technologies, Carlsbad, CA) was used for Caco2 cells and
siLentFect (BioRad, Hercules, CA) for SW480 and SW620 cells.
Controls were transfected with a scrambled oligonucleotide,
the sequence of which was 5′-AAGATT GCGCGACGATGA-3′
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the production of 12(S)-HETE was determined 48 and 96 h
after transfection.
Reverse transcription-PCR analysis of gene expression
Total RNA was isolated from subconfluent cultures or frozen colon
tissue specimens using Trifast (PeqLab, Erlangen, G) and chloro-
form extraction. 5 μg aliquots were used to prepare cDNA using
RevertAid MMuLV reverse transcriptase (Fermentas, Burlington,
Ontario) and random hexamer primers (GE Healthcare, Piscat-
away, NJ, USA).
The expression of 12(S)-LOX mRNA, E-cadherin, integrin β1
and GAPDH was then determined by real time PCR on an ABI
PRISM 7000 system (Applied Biosystems, Foster City, CA, USA)
using Taqman Gene expression assays listed in Table 2 of supple-
mental materials. Quantification of gene expression was calculat-
ed by the ΔΔCt method using GAPDH as the internal control
gene. Selected experiments were also done by standard RT-PCR
using the primers and conditions listed in Table 1 of supplemental
materials.
E-cadherin and integrin β1 on the cell surface
Cells were harvested by limited trypsinisation and washed thor-
oughly. 106 cells were then re-suspended in 100 μl PBS. For detection
of E-cadherin cells were incubatedwith 10 μg/mlmouse anti-human
E-Cadherin (HECD-1; Alexis, San Diego) for 2 h on ice followed by a
1-h incubation with 20 μl of a phycoerythrin-labelled second anti-
body (Rat anti mouse—PE, Becton Dickinson). Detection of integrin
β1 was done using a PE-labelled antibody recognising total integrin
β1 (cloneMAR4, BectonDickinson). Control sampleswere incubated
with control IgG. Analysis was performed using a FACScalibur (Bec-
ton Dickinson).
Western blot
Whole cell lysates were obtained by homogenising cultures in
RIPA buffer (50 mM Tris/HCl pH 7.4, 500 mM NaCl, 1% NP-40,
0.5% Na-DOC, 0.1% SDS, 0.05% NaN3) supplemented with
complete protease inhibitor mix (1:50; Roche Diagnostics,
Mannheim, Germany). Integrin β1 protein levels were deter-
mined by western blotting from 50 μg of protein per lane
using primary antibodies directed against integrin β1 (1:1000;
4706, Cell Signalling, Boston, MA) and β-actin (1:5000; AC-15,
Sigma, St. Louis, MO, USA). Secondary antibodies were conju-
gated to horseradish peroxidase and detection achieved by
chemiluminescence.
12(S)-HETE ELISA
5×104 cells/ well were plated into 24 well plates and 10 μM AA
(Sigma) was added 24 h later. 12(S)-HETE production was deter-
mined from culture supernatants using an indirect ELISA assay
purchased from R&D (Minneapolis, MN) according to the manu-
facturer's instructions. 100 μl of the supernatant were added to
the plates together with an alkaline phosphatase-labelled HETE
as a tracer and polyclonal anti-12(S)-HETE antibody. After 2 h of
incubation at room temperature wells were washed extensively
and bound tracer was detected photometrically.Results
Expression of 12(S)-LOX in colorectal tumours
Expression of 12(S)-LOX was determined by quantitative RT-PCR
from 50 colorectal tumour specimens. For 16 of these tumours the
pathology report described ulcerated areas and/or inflammatory
cells recruited into the tumour tissue. Based on the role of 12-LOX
enzymes in inflammation regulation we chose to analyse these
tumours separately from the remaining 34 tissue specimens for
which no signs of inflammation was reported. Quantification was
obtained relative to the house keeping gene glycerinaldehyd-3-
phosphat-dehydrogenase (GAPDH) and normalised to the respec-
tive normal, tumour-free tissue at the resection margin. The mean
relative expression for the 16 tumour specimens was 2.29±0.52
(range 0.004–7.24; higher than normal mucosa at p=0.0121)
with 12(S)-LOX mRNA up-regulated in 10/16 specimens and
down-regulated in only 2/16. No up-regulation and even down-
regulation was observed in tumour-specimens for which little or
no inflammatory component was described in the pathology report
(mean relative LOX-expression 0.381±0.380; range 0.00001–1.14).
Calculation relative to ß-actin and microglobulin as alternative
house keeping genes did not alter the results (data not shown).
Biological effects of 12(S)-HETE on colorectal cancer cells
To investigate the biological impact of 12(S)-LOX expression and
the 12(S)-HETE product on colorectal cancer cells cell line models
were chosen due to their endogenous 12(S)-LOX expression levels
(see supplemental materials). To assess the biological effects of
the 12(S)-LOX product 12(S)-HETE in colorectal tumour cells the
mediator was diluted into the medium of SW620, SW480 and
Caco2 cultures and cell number was determined 24 h later. Viabil-
ity was increased by 12(S)-HETE in the highly differentiated,
slowly growing Caco2 cells about 25% above the control. The
eicosanoid did not enhance viability in the rapidly growing
SW480 and SW620 cells (Fig. 1a). However, growth of SW480
cells in soft agar was stimulated by 12(S)-HETE in a concentration
dependent manner (p<0.001 by one-way ANOVA) reaching 1.6-
fold at a concentration of 100 nM. SW620 cells that were obtained
from a lymph node metastasis served as positive control for agar
growth (Fig. 1b). Caco2 cells did not produce sufficient agar colo-
nies to be quantified (data not shown). By contrast, clonogenicity
of SW480 cells was inhibited by 12(S)-HETE (Fig. 1c; p<0.05 by
one-way ANOVA). Effects of 12(S)-HETE on the migration of
SW480 or Caco2 cells were not detected (data not shown).
Over-expression of 12(S)-LOX in colorectal tumour cells
To achieve sustained 12(S)-HETE production 12(S)-LOX over-
expressing cells were constructed from both Caco2 and SW480
cells. The SW480-LOX cultures have been characterised previously
[24]. Stable Caco-LOX transfectants expressed 14-fold higher
levels of 12(S)-LOX compared to vector-transfected cells and
secreted about 5 nM 12(S)-HETE into their medium upon AA addi-
tion (supplemental materials Figure 1s). That amount of mediator
was sufficient to induce increased viability: in the presence of AA
to support 12(S)-HETE production both over-expressing cell
lines achieved a growth and/or survival advantage over the
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Fig. 1 – Effects of 12(S)-HETE on cell number a: Cells were plated in 24-well plates at 5×104 cells/well and left to attach for 24 h
before exposure to 12(S)-HETE. The number of viable cells was determined by neutral red uptake and calculated relative to
controls. ** represents an increase as compared to the respective controls at p<0.01. b: 5000 SW480 or SW620 cells were suspended
in agar medium containing appropriate 12(S)-HETE concentrations to determine anchorage-independent growth. SW620 cells
were used as a positive control for agar growth. After 3 weeks colonies were scored at 4-fold magnification in 2 independent
experiments using triplicate cultures. All data points represent the mean±SD, the overall induction was significant at p<0.001 by
one-way ANOVA, for single column comparison ** and *** indicate an increase above control at p<0.01 and p<0.001 respectively.
c: 100 SW480 cells/well were seeded into 6-well plates using medium supplemented with 12(S)-HETE at the concentrations
indicated and left to attach overnight. The medium together with any cells that had not attached was removed. After the medium
change cultures were maintained in standard growth medium for 1 week. Colonies were fixed, stained with crystal violet and
counted. All data points represent the mean±SD of 2 independent experiments, the overall decrease was significant at p<0.05 by
one-way ANOVA and for single column comparisons # and ## indicate a decrease as compared with control at p<0.05 or 0.01
respectively.
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growth promoting effect was even more obvious in soft agar
media. Colony number obtained from SW480-LOX was increased
1.7-fold above the controls and almost reached the number of col-
onies derived from untransfected SW620, which is a more malig-
nant cell clone producing higher amounts of 12(S)-HETE
(Fig. 2a). The growth of Caco-LOX cells was not sufficient to be
analysed in soft agar assays. By contrast, colony formation was
inhibited by 33% in Caco2 transfectants and by 24% in SW480-
LOX cells which was equal to colony formation in SW620 cultures
(Fig. 2b). Cell migration was stimulated in 12(S)-LOX transfec-
tants as compared to controls so that Caco-LOX cells migratedlike SW480 controls and SW480-LOX cells displayed activity sim-
ilar to SW620 cells (Fig. 2c).
To assess the cells' malignant properties in vivo they were
injected s.c. into the rear flank of SCID mice and tumour growth
monitored for 7 weeks. Both LOX- and control (co)-transfectants
formed tumours of epithelioid, cytokeratin 20 expressing cells
(Fig. 3a) and local tumour growth did not differ between both
groups (Fig. 3b). Metastatic potential was determined from the
presence of Ki67-positive tumour cells in the lungs of tumour
bearing mice. Single metastatic cells were identified in the vicinity
of major vessels (Fig. 3c) and scored from serial sections as
described in Materials and methods. The resulting mean score in
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Fig. 2 – Biological impact of 12(S)-LOX expression. a: 5000 cells each of SW480-co and SW480-LOX were suspended in agar medium
to determine anchorage-independent growth and colonies were scored after 3 weeks. SW620 cells were used as a positive control.
The results represent means±SD of at least 3 independent experiments using triplicate cultures. ** indicates an increase above
SW480-co at p<0.01 by unpaired t-test. b: Cells were plated at 100 (SW480-co, SW480-LOX) or 200 (Caco-co, Caco-LOX, SW620)
cells/well in 6-well plates for assessment of clonogenicity. Mediumwas changed and un-attached cells removed after 24 h. Colonies
were counted after 7 days in culture. Results were calculated per 100 cells and presented as mean±SD of at least 3 independent
experiments with # and ## representing a decrease as compared to the respective control at p<0.05 and 0.01 respectively by
unpaired t-test. c: Cell migration was determined by filter migration assay. After a migration period of 24 h (SW480 transfectants,
SW620) or 48 h (Caco2 transfectants) cells on the bottom of the membrane (Caco2 transfectants) or in the lower chamber (SW480
transfectants and SW620) were fixed, stained with crystal violet and counted. The results represent the mean±SD of 3 independent
experiments using duplicate cultures. * and *** indicate an increase above control at p<0.05 and p<0.001 respectively by unpaired
t-test.
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(Fig. 3d; p=0.0281).
Inhibition of 12(S)-HETE production
For inhibition of 12(S)-LOX-activity the flavonoid baicalein was
used that reduced 12(S)-HETE production with an IC50 of 0.7 μM
and decreased cell viability with an IC50 in the range of 6–8 μM
[24]. In addition the inhibitor blocked cell migration in untrans-
fected SW480 and SW620 cells as well as SW480-co and SW480-
LOX transfectants (Fig. 4a). Baicalein effects on anchorage-
independent growth were determined in SW620 cells and were
also inhibited (Fig. 4b). Unexpectedly, clonogenicity was also
inhibited by 0.7 μM as well as 6 μM baicalein (Fig. 4c) which may
be due to effects of baicalein on other cellular targets that also
cause loss of viability (e.g. growth signalling).To obtain a more specific inhibition 12(S)-LOX expression was
knocked down by anti-sense nucleotides as described by Tang et
al. [26]. In SW620 cells this caused an 80% reduction of 12(S)-
LOX mRNA and 12(S)-HETE production that was maintained for
4 days (supplemental materials Figure 3s a, b). Knock down in
12(S)-LOX over-expressing SW480 and Caco2 cells was less effi-
cient but did reach a ≥50% reduction after 2 transfections both
on the RNA- and the HETE-production level (supplemental mate-
rials Figure 3s c, d, e). This procedure caused an increase in clono-
genicity (Fig. 5a) as well as a reduction in migration (Fig. 5b) and
in anchorage-independent growth (Fig. 5c).
Expression of genes related to cell interactions
For an initial analysis of gene expression Caco2 cells transiently
over-expressing 12(S)-LOX were used because of their high
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isolated from the tumour-bearing mice bearing SW480 tumours and fixed with formalin. Serial sections were stained using
antibodies recognising Ki67 to detect tumour cells (arrows in c). Ki67-positive tumour cells in the lungs were scored according
to the criteria given in materials and methods (d). * indicates a significant increase as compared to control at p=0.0281 by
Mann–Withney test.
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tal materials Figure 2s b). RNA was isolated 24 h after supplemen-
tation of the culture medium with 20 μM AA and 96 metastasis-
related genes were assessed using a focused micro-array. 12 of
these genes produced signals robust enough for analysis and
were significantly down-regulated compared to control (supple-
mental materials Table 3). Prominent among the down-regulated
genes were the cell surface molecules integrin β1 (ITGB1), integ-
rin α5 (ITGA5), and E-cadherin (CDH1). The effect on expression
of these three genes was verified by standard RT-PCR.While integ-
rin α5 did not appear down regulated in the PCR reaction, the in-
hibitory effect could be verified for E-cadherin and integrin β1
(Fig. 6a).
E-cadherin expression was easily detectable on both the RNA
and protein level in Caco2 cells but not in SW480 and SW620 cul-
tures (Figs. 6b, d). E-cadherin protein on the cell surface of SW480
and SW620 was about 10% the amount seen on Caco2 cells
(Fig. 6d). Over-expression of 12(S)-LOX in Caco2 cells induced a
40% reduction of E-cadherin at the cell surface that was reversible
upon knock down of 12(S)-LOX expression (Fig. 6d).Similarly, integrin β1 which is part of the fibronectin and colla-
gen I receptors was expressed in the cell lines in different amounts
(Caco2>SW480>SW620) at both the RNA and the protein levels
(Figs. 6c, e). Over-expression of 12(S)-LOX in both Caco2 and
SW480 cells reduced integrin β1 at the cell surface by 20%
(Fig. 6e) and total integrin β1 by 30% (Fig. 6f). By contrast, inhibi-
tion of 12(S)-LOX by either knock down (SW620, Fig. 6e) or expo-
sure to baicalein (both SW480-LOX and SW620) increased
integrin protein (Fig. 6g).Discussion
12(S)-LOX (ALOX12) introduces a hydroxyl-group at position 12
of arachidonic acid to produce 12(S)-HETE [2,27], a mediator in-
volved in tumour progression and metastasis in melanoma
[28,29], prostate cancer [30], pancreatic cancer [31] as well as in
angiogenesis in several tumour types reviewed in [32]. In prostate
cancer 12(S)-LOX-over expression was correlated with advanced
disease [13,33]. Our study now shows up-regulation of 12(S)-
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was described in the pathology report but not in tumours with lit-
tle signs of inflammation. The study did not use specimens from
IBD or IBD-related cancer. A correlation with staging or grading
parameters could not be observed. This is in agreement with a re-
cent survey of eicosanoid levels in colorectal tumours that did not
report a general increase in 12(S)-HETE [34] andmay indicate that
both enzyme and product may be derived from or produced as a
reaction to the inflammatory tumour microenvironment.
In colorectal cancer cell lines 12(S)-LOX expression was gener-
ally low except for SW620 cells that were obtained from a lymph
nodemetastasis. This cell line produced about twice the amount of
12(S)-HETE when compared with SW480 cells that originated
from the respective primary tumour and the well differentiated
Caco2 cells. Other cell lines derived from metastases (e.g. T84)
did not produce more LOX or HETE. For this two explanationsare possible: (1) 12(S)-LOX expression is not tumour cell autono-
mous, but arises from the tumour microenvironment or (2) 12(S)-
LOX expression is transiently up-regulated in response to an in-
flammatory micro-environment.
Independent of their source the results obtained with our in
vitro models suggests a role of the enzyme and its product in tu-
mour progression and metastasis. 12(S)-HETE increased cell via-
bility in standard cultures of the well differentiated, slowly
growing cell line Caco2. In cultures of SW480 and SW620 cells
that already have a much higher growth potential the mediator
had no additional impact on growth under standard conditions,
but it strongly supported anchorage-independent growth of
SW480 cells. Effective concentrations in both cases were 10 and
100 nM. Similarly, over-expression of 12(S)-LOX in Caco2 or
SW480 cells conferred a growth/survival advantage in standard
cultures and increased growth of SW480-LOX over-expressing
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Fig. 5 – Knock-down of 12(S)-LOX expression. Anti-sense oligonucleotides were introduced into the cells by lipofection according
to the transfection scheme described in supplemental materials. This achieved a ≥50% reduction of 12(S)-LOX expression and
12(S)-HETE production (supplemental materials Figure 4s). At the time point when expression was at the minimum cells were
(a) plated for clonogenicity assays, (b) placed into filter inserts for migration assays and (c) suspended in soft agar medium to
determine anchorage-independent growth. All data points represent the mean±SEM of at least 2 independent experiments using
triplicate cultures. * indicates increased above control at p<0.05; #, and ## a decrease as compared to control at p<0.05 and 0.01
respectively.
775E X P E R I M E N T A L C E L L R E S E A R C H 3 1 8 ( 2 0 1 2 ) 7 6 8 – 7 7 8cells in soft agar media. Over-expressing cell lines secreted about
5–10 nM 12(S)-HETE into their media, which on the low end of
the concentration range for which biological effects of exogenous
12(S)-HETE have been observed in our cells. As endogenous
HETE has a limited half-life when exposed to oxygen, it may well
be less effective than HETE continuously produced in an autocrine
manner.
Both our results from HETE-exposed cells and from 12(S)-LOX
over-expressers confirm reports assigning survival activity to
12(S)-HETE in other tumour types [26,35,36]. In addition, 12(S)-
LOX expression reduced clonogenicity which under our condi-
tions—removal of non-attached cells after 24 h—largely reflects
decreased cell attachment. Concomitantly cell migration in Caco2
and SW480 cells was stimulated effectively increasing their
capability to invade. The combined results from the functional as-
says (clonogenicity, anchorage-independent growth, cell migra-
tion) define a malignant phenotype increasing in the sequence
Caco2<SW480<SW620. Over-expression of 12(S)-LOX reducedclonogenicity but stimulated anchorage-independent growth and
cell migration. In summary these biological effects shift the tu-
mour cell characteristics towards higher degrees of malignancy.
An impact on the expression of cyclooxygenase-2 (COX-2) and
vascular endothelial growth factor (VEGF) that also indicate tu-
mour progression was not observed in our analysis (data not
shown).
In vivo SW480-LOX cells did not form larger tumours than the
respective controls, which seems to indicate that the growth and
survival impact of 12(S)-HETE is not sustained in vivo. With
regard to this observation it has to be taken into account that
SW480 cells already have a very high potential for local tumour
growth so that it may not be possible to increase it further—
similar to the absence of a 12(S)-HETE growth effect in standard
cultures. LOX-over-expressing SW480 cells did, however, have a
stronger tendency to metastasise in line with their increased
growth capacity in soft agar and enhanced migratory potential.
Again this indicates a more aggressive phenotype. A reverse shift
776 E X P E R I M E N T A L C E L L R E S E A R C H 3 1 8 ( 2 0 1 2 ) 7 6 8 – 7 7 8was achieved by inhibition of LOX-activity by baicalein or by
knock-down of 12(S)-LOX expression in SW620 cells as well as
Caco2-LOX and SW480-LOX transfectants demonstrating LOX-
dependency of the effects.
Pro-metastatic effects of 12(S) HETE have also been de-
scribed for breast cancer cells where the mediator comes from
15-LOX-1 (ALOX15) and enhanced intravasation into lymph
vessels [15]. The HETE induces migration of the lymph endo-
thelial cells in an NFκB-dependent manner in these cells [37].ba
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anchorage-independent growth [33], similar to our observa-
tions. Attachment and spreading on the matrix proteins fibro-
nectin and collagen I was increased in the 12-LOX over-
expressing prostate cells [33]. By contrast, 12(S)-LOX over-
expressing colon cancer cells displayed decreased colony for-
mation using an assay format reflecting both cell attachment
and growth potential. As viability assays indicate a positive
effect of 12(S)-HETE on growth and survival, we do concludec
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777E X P E R I M E N T A L C E L L R E S E A R C H 3 1 8 ( 2 0 1 2 ) 7 6 8 – 7 7 8that in contrast to prostate cancer cells colon carcinoma cells de-
crease their interaction with the culture substrate in response to
the mediator. This is also supported by the down-regulation of
integrin β1 protein which is part of the receptors for both fibro-
nectin and collagen I [38] by 12(S)-LOX over-expression in both
Caco2 and SW480 cells. Integrin β1 has been shown to inhibit
cell migration [39] and is lost in advanced colorectal tumours
[40]. Its down-regulation was reversed by both baicalein and
12(S)-LOX knock-down indicating that 12(S)-HETE is instru-
mental in this process.
In Caco2 cells not only integrin β1 was subject to down-
regulation by 12(S)-LOX, but E-cadherin was similarly reduced
diminishing cell-cell contacts in a 12(S)-LOX-dependent manner.
Like many other malignant cells the more undifferentiated cell
lines SW480 and SW620 did no longer express detectable
amounts of E-cadherin, as it is lost with tumour progression and
epithelial mesenchymal transition [41].
In summary, our results show the induction of a migratory,
metastatic phenotype in 12(S)-LOX transfected colorectal tumour
cells. This is a pre-requisite for metastasis while the cells move to-
wards the metastatic site.Conﬂict of interest statement
None of the authors have any conflict of interest to declare.Acknowledgments
This work was supported by a grant from the Austrian Science
Fund (P16328).Appendix A. Supplementary data
Supplementary data to this article can be found online at doi:10.
1016/j.yexcr.2011.12.017.Fig. 6 – Differential expression of cell surface molecules. a: RNA was
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and 0.01 by Mann–Withney test. b, c: RNA was isolated for the dete
qRT-PCR. Results are shown relative to GAPDH expression. ### ind
t-test. d, e: Untransfected cultures (Caco2, SW480, SW620) and Cac
semi-confluence. In Caco-LOX cells 12(S)-LOX expression was knoc
(as-scr Caco-LOX and as-LOX Caco-LOX) and cultures were used at
(d) and integrin β1 (e) on the cell surface was determined by FACS a
of protein expression. The data were normalised to Caco2 or the res
results from 3 independent experiments using duplicate measurem
respective controls at p<0.05; 0.01 or 0.001. * represents an increa
semi-confluence and then homogenised in lysis buffer for determi
representative blots above the column of semi-quantitative assessm
experiments using duplicate lanes and # indicates a decrease at p<
semi-confluence and then exposed to 0.7 μM or 6 μM baicalein in se
determined as described above. All data points represent the mean
* increased above control at p<0.05.R E F E R E N C E S
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